Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 315

1.

Mesenteric lymph diversion abrogates 5-lipoxygenase activation in the kidney following trauma and hemorrhagic shock.

Stringham JR, Moore EE, Gamboni F, Harr JN, Fragoso M, Chin TL, Carr CE, Silliman CC, Banerjee A.

J Trauma Acute Care Surg. 2014 May;76(5):1214-21. doi: 10.1097/TA.0000000000000231.

PMID:
24747451
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy.

de Zeeuw D, Coll B, Andress D, Brennan JJ, Tang H, Houser M, Correa-Rotter R, Kohan D, Lambers Heerspink HJ, Makino H, Perkovic V, Pritchett Y, Remuzzi G, Tobe SW, Toto R, Viberti G, Parving HH.

J Am Soc Nephrol. 2014 May;25(5):1083-93. doi: 10.1681/ASN.2013080830. Epub 2014 Apr 10.

PMID:
24722445
[PubMed - indexed for MEDLINE]
3.

Evaluation of the effects of a therapeutic renal diet to control proteinuria in proteinuric non-azotemic dogs treated with benazepril.

Cortadellas O, Talavera J, Fernández del Palacio MJ.

J Vet Intern Med. 2014 Jan-Feb;28(1):30-7. doi: 10.1111/jvim.12246. Epub 2013 Dec 26.

PMID:
24372810
[PubMed - indexed for MEDLINE]
4.

Eplerenone-mediated aldosterone blockade prevents renal fibrosis by reducing renal inflammation, interstitial cell proliferation and oxidative stress.

Chen H, Sun F, Zhong X, Shao Y, Yoshimura A, Liu Y.

Kidney Blood Press Res. 2013;37(6):557-66. doi: 10.1159/000355736. Epub 2013 Nov 26.

PMID:
24296802
[PubMed - indexed for MEDLINE]
5.

Cardiovascular and renal effects of high salt diet in GDNF+/- mice with low nephron number.

Schlote J, Schröder A, Dahlmann A, Karpe B, Cordasic N, Daniel C, Hilgers KF, Titze J, Amann K, Benz K.

Kidney Blood Press Res. 2013;37(4-5):379-91. doi: 10.1159/000355716. Epub 2013 Sep 27.

PMID:
24247178
[PubMed - indexed for MEDLINE]
6.

[A cross-sectional study of renal function based on estimated glomerular filtration rate and urinary protein levels related to risk factors for cardiovascular events and metabolic syndrome in local residents].

Imawatari R, Kawabe S, Tanda T, Ogawa M, Hamao Y, Matsuda E, Uno T, Tanaka Y, Kagiyama A, Okamoto T, Kanai H, Yanagida T, Ouma H.

Nihon Koshu Eisei Zasshi. 2013 Aug;60(8):453-61. Japanese.

PMID:
24125767
[PubMed - indexed for MEDLINE]
Free Article
7.
8.

Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.

Karalliedde J, Maltese G, Hill B, Viberti G, Gnudi L.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1899-905. doi: 10.2215/CJN.02700313. Epub 2013 Aug 8.

PMID:
23929932
[PubMed - indexed for MEDLINE]
9.

[Change and significance of urinary smad3 in type 2 diabetic nephropathy].

Guo KF, Kou JX, Lu JX, Zhang L, Yu HY, Chen HB.

Zhonghua Yi Xue Za Zhi. 2013 Apr 9;93(14):1067-71. Chinese.

PMID:
23902838
[PubMed - indexed for MEDLINE]
10.

Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study.

Chang A, Batch BC, McGuire HL, Vollmer WM, Svetkey LP, Tyson CC, Sanguankeo A, Anderson C, Houston J, Appel LJ.

Am J Kidney Dis. 2013 Nov;62(5):900-7. doi: 10.1053/j.ajkd.2013.04.022. Epub 2013 Jun 28.

PMID:
23810691
[PubMed - indexed for MEDLINE]
11.

Advanced IgA nephropathy with impaired renal function benefits from losartan treatment in rats.

Wang H, Fu W, Jin Z, Wang Y, Yao W, Yin P, Peng W.

Ren Fail. 2013 Jul;35(6):812-8. doi: 10.3109/0886022X.2013.794686. Epub 2013 May 28.

PMID:
23751143
[PubMed - indexed for MEDLINE]
12.

Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietary protein amounts.

Jesudason DR, Pedersen E, Clifton PM.

Am J Clin Nutr. 2013 Aug;98(2):494-501. doi: 10.3945/ajcn.113.060889. Epub 2013 May 29.

PMID:
23719550
[PubMed - indexed for MEDLINE]
Free Article
13.

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial.

Pitt B, Kober L, Ponikowski P, Gheorghiade M, Filippatos G, Krum H, Nowack C, Kolkhof P, Kim SY, Zannad F.

Eur Heart J. 2013 Aug;34(31):2453-63. doi: 10.1093/eurheartj/eht187. Epub 2013 May 27.

PMID:
23713082
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial.

Tirosh A, Golan R, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Rudich A, Kovsan J, Fiedler GM, Blüher M, Stumvoll M, Thiery J, Stampfer MJ, Shai I.

Diabetes Care. 2013 Aug;36(8):2225-32. doi: 10.2337/dc12-1846. Epub 2013 May 20.

PMID:
23690533
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa.

Schiffmann R, Ries M, Blankenship D, Nicholls K, Mehta A, Clarke JT, Steiner RD, Beck M, Barshop BA, Rhead W, West M, Martin R, Amato D, Nair N, Huertas P.

Genet Med. 2013 Dec;15(12):983-9. doi: 10.1038/gim.2013.56. Epub 2013 May 16.

PMID:
23680766
[PubMed - indexed for MEDLINE]
16.

Determinants of arterial stiffness in chronic kidney disease stage 3.

McIntyre NJ, Fluck RJ, McIntyre CW, Fakis A, Taal MW.

PLoS One. 2013;8(1):e55444. doi: 10.1371/journal.pone.0055444. Epub 2013 Jan 30.

PMID:
23383192
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.

Dhaun N, Melville V, Blackwell S, Talwar DK, Johnston NR, Goddard J, Webb DJ.

J Am Soc Nephrol. 2013 Jan;24(1):31-6. doi: 10.1681/ASN.2012040355. Epub 2012 Dec 14.

PMID:
23243212
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy.

Titan SM, Vieira JM Jr, Dominguez WV, Moreira SR, Pereira AB, Barros RT, Zatz R.

J Diabetes Complications. 2012 Nov-Dec;26(6):546-53. doi: 10.1016/j.jdiacomp.2012.06.006. Epub 2012 Sep 12.

PMID:
22981148
[PubMed - indexed for MEDLINE]
19.

Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker.

Fukuda A, Wickman LT, Venkatareddy MP, Wang SQ, Chowdhury MA, Wiggins JE, Shedden KA, Wiggins RC.

Nephrol Dial Transplant. 2012 Nov;27(11):4079-87. doi: 10.1093/ndt/gfs313. Epub 2012 Aug 3.

PMID:
22863839
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.

Lekawanvijit S, Kompa AR, Manabe M, Wang BH, Langham RG, Nishijima F, Kelly DJ, Krum H.

PLoS One. 2012;7(7):e41281. doi: 10.1371/journal.pone.0041281. Epub 2012 Jul 19.

PMID:
22829936
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk